Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Home
Company
Teva
Teva
Activities:
Manufacturing
Ingredients
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Legionella testing: Modern alternatives to the ‘gold standard’ test
The development of significantly faster, more sensitive testing protocols provide more options for detection Legionella than the complex plate culture test, but these also have...
Industry 4.0: What is the advantage of real-time digital signage?
Olivia Fernandez from Digital Therapeutics (DTx) disusses how digital signage can serve in cleanrooms as a versatile and powerful tool that allows those in charge to ensure...
Integrity testing of HEPA filters: A practical approach
Filtering the air in aseptic process areas is critical to maintaining the cleanliness of the production environment. Jesus Casas provides tips to ensure HEPA filters are fit...
Impact of the new Annex 1 on sterile filling in pharma
EU GMP Annex 1 is a whole new era for the sterile filling industry. From barrier technology to “first air”, pharmaceutical manufacturers have a lot to decide. Johannes...
What is ISO 8 cleanroom classification?
Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
Upcoming event
Clinical Pharmacy Congress
10-11 May 2024 | Conference | London, UK
See all
Related Content
Manufacturing
Teva Pharmaceuticals gives a look into each step of sterile medicine production
Teva Pharmaceuticals has released a video showing production steps at a site that manufactures 480 million doses a year
Research & Development
Teva completes facilities purchase in Pennsylvania
Investment will see the Israeli drug-maker set up a Research & Development campus in the US
Pharmaceutical
Teva sells UK and Ireland Actavis assets and operations
The buyer Accord Healthcare, a subsidiary of Intas Pharmaceuticals, will takeover the Barnstaple manufacturing plant
You need to be a subscriber to read this article.
Click here
to find out more.
Regulatory
Hot topics in microbiology
A risk-based approach to microbial control in pharmaceutical production was a recurrent theme at the 21st Pharmig microbiology conference. Susan Birks reports on recent changes to standards
Subscribe now